These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16093560)

  • 1. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
    Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
    J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative statistical parameter for high-throughput screening assay quality assessment.
    Sui Y; Wu Z
    J Biomol Screen; 2007 Mar; 12(2):229-34. PubMed ID: 17218666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling.
    Digan ME; Pou C; Niu H; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):615-23. PubMed ID: 16103416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors.
    Gellibert F; Woolven J; Fouchet MH; Mathews N; Goodland H; Lovegrove V; Laroze A; Nguyen VL; Sautet S; Wang R; Janson C; Smith W; Krysa G; Boullay V; De Gouville AC; Huet S; Hartley D
    J Med Chem; 2004 Aug; 47(18):4494-506. PubMed ID: 15317461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).
    Goldberg FW; Ward RA; Powell SJ; Debreczeni JE; Norman RA; Roberts NJ; Dishington AP; Gingell HJ; Wickson KF; Roberts AL
    J Med Chem; 2009 Dec; 52(23):7901-5. PubMed ID: 19736928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling.
    Woodward PW; Williams C; Sewing A; Benson N
    J Biomol Screen; 2006 Feb; 11(1):5-12. PubMed ID: 16234338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
    Peters MF; Knappenberger KS; Wilkins D; Sygowski LA; Lazor LA; Liu J; Scott CW
    J Biomol Screen; 2007 Apr; 12(3):312-9. PubMed ID: 17307886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
    Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
    Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput determination of mode of inhibition in lead identification and optimization.
    Wei M; Wynn R; Hollis G; Liao B; Margulis A; Reid BG; Klabe R; Liu PC; Becker-Pasha M; Rupar M; Burn TC; McCall DE; Li Y
    J Biomol Screen; 2007 Mar; 12(2):220-8. PubMed ID: 17351185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
    Hubert CL; Sherling SE; Johnston PA; Stancato LF
    J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
    Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
    Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
    Perrin D; Frémaux C; Scheer A
    J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery.
    Lo MC; Aulabaugh A; Jin G; Cowling R; Bard J; Malamas M; Ellestad G
    Anal Biochem; 2004 Sep; 332(1):153-9. PubMed ID: 15301960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery.
    Mondal MS; Gabriels J; McGinnis C; Magnifico M; Marsilje TH; Urban L; Collis A; Bojanic D; Biller SA; Frieauff W; Martus HJ; Suter W; Bentley P
    Toxicol Sci; 2010 Nov; 118(1):71-85. PubMed ID: 20631060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
    Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
    J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).
    Li X; Wang L; Long L; Xiao J; Hu Y; Li S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4868-72. PubMed ID: 19616940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.